Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Net Margin (2019 - 2025)

Pulmonx (LUNG) has disclosed Net Margin for 7 consecutive years, with 64.89% as the latest value for Q3 2025.

  • Quarterly Net Margin rose 453.0% to 64.89% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 61.83% through Sep 2025, up 1022.0% year-over-year, with the annual reading at 67.3% for FY2024, 2129.0% up from the prior year.
  • Net Margin for Q3 2025 was 64.89% at Pulmonx, down from 63.59% in the prior quarter.
  • The five-year high for Net Margin was 55.28% in Q4 2024, with the low at 146.76% in Q1 2022.
  • Average Net Margin over 5 years is 88.72%, with a median of 84.33% recorded in 2023.
  • Peak annual rise in Net Margin hit 21926bps in 2021, while the deepest fall reached -5224bps in 2021.
  • Over 5 years, Net Margin stood at 94.88% in 2021, then increased by 2bps to 92.6% in 2022, then rose by 22bps to 72.16% in 2023, then rose by 23bps to 55.28% in 2024, then dropped by -17bps to 64.89% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 64.89%, 63.59%, and 63.95% for Q3 2025, Q2 2025, and Q1 2025 respectively.